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Background: Congenital diaphragmatic hernia (CDH) can be repaired on or off extracorporeal
membrane oxygenation (ECMO). In many centers, operating off ECMO is advocated to prevent
bleeding complications. We aimed to compare surgery-related bleeding complications between repair on
or off ECMO.
Methods: All patients with CDH repair and ECMO treatment between January 1, 1995, and May 31,
2008, were retrospectively reviewed. Tranexamic acid was routinely given to all patients repaired on
ECMO for 24 hours perioperatively after 2003. Extra-fluid expansion, transfusion, or relaparotomy
caused by postoperative bleeding were scored as surgery-related bleeding complications and were related
to the Extracorporeal Life Support Organization (ELSO) registry. We used χ2 test and t test for statistics.
Results: Demographic data and surgery-related bleeding complications in the on-ECMO group were not
significantly different compared with the off-ECMO group (P = .331) in our institute. In contrast, more
surgery-related bleeding complications were reported by ELSO in their on-ECMO group (P b .0001).
Conclusion: In contrast to the data from the ELSO registry, we did not observe significantly more surgery-
related bleeding complications after CDH repair on ECMO. Using a specific perioperative hemostatic
treatment enabled us to perform CDH repair on ECMO with a low frequency of bleeding complications,
thereby taking advantage of having the physiologic benefits of ECMO available perioperatively.
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Open access under the Elsevier OA license.Congenital diaphragmatic hernia (CDH) is a develop-
mental defect in the diaphragm resulting in herniation of the
abdominal viscera into the thorax. The incidence of CDH is
approximately 1 in 2200 live births. The primary de-
terminants of mortality in patients with CDH are the degree
of associated pulmonary hypoplasia (PH) and persistent
pulmonary hypertension (PPH) (reviewed in Sluiter et al [1]).
The treatment of CDH consists of preoperative stabilization
632 R. Keijzer et al.directed toward optimal management of PH and PPH,
followed by surgical repair of the diaphragmatic defect either
primarily or with a patch [2].
Treatment of CDH remains a challenge for both pediatric
surgeons and pediatric intensive care specialists. Survival of
these children has improved substantially during the past
decades. Better antenatal diagnosis and advances in neonatal
intensive care after the introduction of gentle ventilation
strategies are responsible for this improvement [3].
One of the treatment modalities for CDH in the neonatal
period is extracorporeal membrane oxygenation (ECMO);
ECMO provides a temporary cardiopulmonary bypass system
to overcome reversible lung failure. Respiratory failure may be
attributed to PPH and/or PH that is associated with CDH [3-5].
Survival rates for patients with CDH undergoing ECMO
treatment currently range from44% to 86% [6]. Extracorporeal
membrane oxygenation has been available in our institution
since 1993. Indications for ECMO treatment of babies with
CDH in our institution are failure of maximal conventional
therapy and fulfillment of strict ECMO criteria predicting an
80% mortality, as published previously [7]. Different criteria,
however, exist between institutions with respect to when to
initiate ECMO treatment [8,9].
In 2002, the CDH study group reported that 54% of
infants with CDH placed on ECMO underwent repair of the
diaphragmatic defect while on ECMO [8]. Timing of CDH
repair in patients requiring ECMO remains controversial and
is dependent on local protocols [6]. One of the reasons to
operate subsequent to ECMO treatment is the concern of
surgery-related bleeding complications. Hemorrhage, in
general, is a major complication in neonates on ECMO [8].
The aim of our study was to determine the number of
surgery-related bleeding complications in patients undergo-
ing CDH repair on ECMO and to compare this number with
those undergoing CDH repair off ECMO in our institution.
We were able to perform this study because we initially
started CDH repair after ECMO treatment but switched to
CDH repair while on ECMO after establishing a new
protocol to prevent bleeding complications in 2003. We
observed no significant differences in surgery-related
bleeding complications between the on-ECMO and off-
ECMO CDH repair groups in our institution. Subsequently,
we compared these results with those of the Extracorporeal
Life Support Organization registry (ELSO registry) and
found that there were a significantly higher number of
surgery-related bleeding complications in the on-ECMO
CDH repair group in the ELSO registry.1. Materials and methods
1.1. Eligibility criteria
We retrospectively reviewed all charts of patients
undergoing open abdominal CDH repair while on ECMOor after ECMO treatment in our institution between January
1, 1995, and May 31, 2008.
1.2. Surgery
During this study period, all patients underwent open
operative CDH repair, and all surgeons used a subcostal
incision. Diaphragmatic defects were closed using either
nonabsorbable interrupted sutures or a Goretex patch (W. L.
Gore & Associates, Inc., Flagstaff, AZ), according to the
choice of the attending surgeon. All patients undergoing
repair on ECMO were operated on in the intensive care unit
(ICU), whereas off-ECMO patients underwent repair in the
operating room.
1.3. ECMO protocol in our institute
During the study period, the same circuit, type of tubing,
and roller pump were used in all patients. Hemolysis was
evaluated on a daily basis as discussed later in more detail.
Since 2003, all patients in our institute are treated with
tranexamic acid (TEA; Cyklokapron; Pfizer, Capelle a/d
Ijssel, The Netherlands) perioperatively until 24 hours
postoperatively. In detail, a loading dose (4 mg/kg) is
given 1 hour before surgery and continued for 24 hours
postoperatively as a drip at 1 mg kg−1 h−1. Platelet levels
are maintained greater than 100,000 mm3, fibrinogen levels
are greater than 1 g/l and activated clotting times levels are
decreased by 20% (reference values, 200-230 seconds) for
24 hours. Clotting status is evaluated after the procedure by
measuring platelets, hemoglobin level, fibrinogen level,
activated partial thromboplastin time, and factor V Leiden,
and levels are corrected if necessary. If the fibrinogen level
is lower than 1 g/l, fibrinogen (Haemocomplettan; CSL
Behring, Breda, the Netherlands) is given in doses of 0.5 to
1 g as a drip for 30 minutes.
1.4. Variables
The following demographic data were collected for all
patients treated in our institution: sex, gestational age in
weeks, birth weight in kilograms, Apgar score at 1 minute,
side of the diaphragmatic defect (left/right), type of CDH
repair (primary or patch), ECMO mode (venous-arterial or
venovenous), and age at repair in days.
The group of patients undergoing CDH repair on ECMO
was compared with the group undergoing repair after
cessation of ECMO. The primary outcome measure was the
occurrence of surgery-related bleeding complications.
Surgical site bleeding was scored positive if extra-fluid
expansion, transfusion, or relaparotomy caused by postop-
erative bleeding was reported in the charts and data derived
from our data management system (patient data manage-
ment system, or PDMS). This is a computer-based
prospective collection of all physiologic parameters
Table 1 Demographic data from Erasmus MC–Sophia
Repair on
ECMO
Repair off
ECMO
P
n 32 16
Birth weight (kg),
mean ± SD
3.04 ± 0.65 3.21 ± 0.43 .714 a
Gestational age (wk),
mean ± SD
38.63 ± 1.76 39.0 ± 1.15 .121 a
Sex (M/F), no. 21/11 8/8 .297 b
Side hernia (left/right) 15/1 29/3 .348 b
Median Apgar score at
1 min (IQR)
5 (2) 7 (4) .124 c
M indicates male; F, female.
a t Test.
b χ2 test.
c Mann-Whitney U nonparametric test.
Table 2 Bleeding complications: Erasmus MC–Sophia vs
ELSO registry
Surgery-related
bleeding
complications
Total
Yes No
(A) Erasmus MC–Sophia
On ECMO 4 28 32
Off ECMO 1 15 16
(B) ELSO registry
On ECMO 616 1614 2230
Off ECMO 34 1075 1109
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eventually, ECMO settings. Because of the change in
timing of CDH repair over time in our institution, analysis
was performed in 3 subgroups, indicative of 3 different
periods, to try to eliminate other confounding treatment
factors that might influence the primary outcome. The entire
patient population with CDH was, thus, subdivided into
3 groups to indicate the number of patients operated on or
off ECMO. During the study period, the entry criteria for
ECMO in CDH did not change.
Secondary outcome measures were length of stay in ICU
in days, duration of mechanical ventilation in days, ECMO
runtime in days, and duration of CDH repair in minutes.
1.5. Comparison with the ELSO registry
Data derived from the ELSO registry were used to
correlate our data to a large international patient cohort. All
patients with CDH undergoing repair in this registry from
1984 until 2008 who had ECMO treatment were included,
and surgery-related bleeding complications were compared
with those findings in our institution. Surgical site bleeding
was scored positive according to the supplied data from the
ELSO registry database.
1.6. Statistics
Three investigators collected data from patient charts and
existing databases in an Excel spreadsheet (Microsoft Excel
Redmond, WA 98052, USA). Subsequently, all data were
exported to SPSS for statistical analysis (SPSS, Chicago, IL).
Normally distributed continuous variables were compared
using the Student t test, whereas nonnormally distributed
variables were analyzed using the Mann-Whitney U non-
parametric test. To compare categorical variables, χ2 and
Fisher exact tests were performed. A P value less than .05
was considered statistically significant.
The institutional review board of Erasmus MC–Sophia,
Rotterdam, the Netherlands, approved the study.
2. Results
2.1. Results from Erasmus MC–Sophia
Between January 1995 and May 2008, 195 patients with
CDH were admitted to our institution. Of this group, 129
(66.2%) underwent repair of the diaphragmatic defect.
Initially, survival was 50% and has increased over the years
to 85% during the last 3 years [10]. Of all the patients
undergoing CDH repair, 51 (39.5%) required ECMO
treatment. Three patients underwent CDH repair and required
ECMO treatment afterward; these patients were excluded
from this study. All patients underwent venous-arterial
ECMO. Demographic data are summarized in Table 1. Sex,
mean gestational age at birth, mean birth weight, side of thehernia, and median APGAR score after 1 minute were not
significantly different.
In our institution, surgery-related bleeding complications
after CDH repair on ECMO (4/32 patients, or 12.5%) were
higher but not significantly different from surgery-related
bleeding complications after repair off ECMO (1/16 patients,
or 6.25%) (P = .652; see Table 2). Changes in management
over time could result in potential bias, and therefore, a
subgroup analysis was performed for 3 different periods:
1995 to 1999, 2000 to 2004, and 2005 to 2008. Since 2005,
CDH repair in patients requiring ECMO was only performed
on ECMO (Fig. 1). In contrast, during the first study period
when ECMO was instituted (1995-1999), half of the patients
had CDH repair off ECMO.
2.2. Results of surgical site bleeding from the
ELSO registry
The group of patients undergoing CDH repair on ECMO
was larger than that off ECMO in the ELSO registry during
all periods (Fig. 2). The ELSO registry registered surgical
site bleeding in its database for all patients that had repair of
their CDH. Table 2B demonstrates that between 1984 and
Fig. 1 The number of patients operated on or off ECMO during 3
different periods. After 2005, all patients were operated on ECMO.
Table 3 Surgical data
Repair on
ECMO
Repair off
ECMO
P
Primary/patch closure a 2/28 2/14 .602 b
Time of repair (h),
median (IQR)
2.00 (0.65) 1.9 (1.07) .188 c
Age at repair (d),
median (IQR)
5.0 (5.0) 20.5 (22.50) .000 c
a Missing values: for 2 patients, information on whether a patch was
used for the repair could not be retrieved.
b χ2 Test.
c Mann-Whitney U nonparametric test.
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undergoing CDH repair on ECMO were reported to have
surgical site bleeding compared with 34 (3.07%) of 1109
patients undergoing CDH repair off ECMO (P b .0001).
2.3. Secondary outcome measures of Erasmus
MC–Sophia
2.3.1. Surgical data
Surgical data are summarized in Table 3. The number
of patients undergoing CDH repair using a patch was 42
(87.5%) and was not significantly different in both groups.
In the repair on ECMO group, 6.6% (2/30) had a primary
repair compared with 12.5% (2/16) in the off-ECMO repair
group (P = .602). For 2 patients, it was not known whether
the repair was done by using a patch or by primary closure
of the diaphragmatic defect. Operating time between the
2 groups was also not different. The median operating time
was 2.0 hours in the on-ECMO repair group compared
with 1.9 hours in the off-ECMO repair group (P = .188).
Patients undergoing CDH repair on ECMO were signifi-
cantly younger compared with those repaired off ECMO.
The median age at repair in the on-ECMO repair group
was 5.0 days (interquartile range [IQR], 5 days) comparedFig. 2 The number of patients operated on or off ECMO during
4 different periods, as registered in the ELSO registry database.with 20.5 days (IQR, 23 days) in the off-ECMO repair
group (P b .0001).
2.3.2. Extracorporeal membrane oxygenation/
ventilation data
There was no difference in days of admission to the ICU
and duration of mechanical ventilation between the 2 groups
(Table 4). Patients undergoing repair on ECMO had a median
ICU stay of 37 days (IQR, 59 days) compared with 57 days
(IQR, 62 days) in the group that had repair after ECMO (P =
.404). The median number of days requiring mechanical
ventilation was 21 days (IQR, 28 days) in patients undergoing
repair on ECMO compared with 28 days (IQR, 34 days) in
those undergoing repair off ECMO. However, ECMO
runtime was significantly less in the off-ECMO repair
group. Median ECMO runtime in the group that had repair
on ECMO was 9.77 days (IQR, 8 days) compared with
7.11 days (IQR, 5 days) in the off-ECMO group (P = .041).3. Discussion
To our knowledge, this is the first study to demonstrate the
feasibility of neonatal CDH repair on ECMO using a specific
anticoagulant protocol. Although we found a higher bleeding
complication rate in the group repaired on ECMO, this
percentage was not statistically significant and lower than theTable 4 ECMO/ventilation data
Repair on
ECMO
Repair off
ECMO
P
ECMO runtime (d),
median (IQR)
9.77 (8) 7.11 (5) .041 a
Time on mechanical
ventilator (d),
median (IQR)
21 (28) 27.67 (33.63) .552 a
Time on ICU (d),
median (IQR)
37 (59.23) 57 (62) .404 a
a Mann-Whitney U nonparametric test.
635Congenital diaphragmatic hernianumber reported in the ELSO registry. This is despite the fact
that the definition of surgery-related bleeding complications
was less well defined in the ELSO registry as compared with
our group. This corroborates previous reports that observed
more surgery-related bleeding complications when repair was
done on ECMO [11-13]. In addition, we observed a trend
toward a shorter length of stay in the ICU in the on-ECMO
repair group as well as a trend toward a shorter duration of
mechanical ventilation in the on-ECMO repair group com-
pared with the off-ECMO repair group. However, changes in
management over time have certainly contributed [10,14].
Results from the ELSO registry indicate that currently
more patients with CDH treated with ECMO are operated
on ECMO than off ECMO internationally. In 1997, van
der Staak et al [11] reported that repair on ECMO may
increase the risk of bleeding complications and that these
complications can be a hallmark of poor outcome. The
administration of TEA is effective in reducing hemorrhagic
complications but might increase the risk of thrombotic
complications. However, after introducing our specific
perioperative bleeding prevention protocol, we did not
observe more clotting problems in the ECMO circuit
and/or oxygenator. Since the establishment of a protocol to
prevent complications from bleeding in 2003, we used
TEA during all our repairs on ECMO, and data from the
ELSO registry database did not indicate the use of TEA. In
addition to the importance of antifibrinolytic agents in a
specific perioperative bleeding prevention protocol like
ours, the importance of delicate and meticulous surgical
technique should not be underestimated.
Vazquez and Cheu [12] report that surgery-related site
bleeding complications, as well as overall hemorrhagic
complications, were significantly higher in patients under-
going CDH repair on ECMO. These data also included the
data from the ELSO registry and were derived from 88
ECMO centers during the period of January 1989 until
December 1991. In addition, they reported that patients
repaired on ECMO are more prone to have acidosis and
hypoxia compared with those that had repair off ECMO.
However, both acidosis and hypoxia were associated with
hemorrhage, and the authors did not report significant
differences in these parameters between both groups.
Another retrospective study performed by Sigalet et al [13]
in 1995 demonstrated that in a group of 60 patients with
CDH, the 9 patients who had repair on ECMO required a
significantly higher transfusion volume and advised against
repair of CDH on ECMO.
One of the limitations of our study is the small number
of patients (N = 48). The low observed frequencies of
bleeding complications in both groups of our series make it
difficult to draw firm conclusions about significant
differences. However, a more relevant finding from our
study is that we observed only 12.5% bleeding complica-
tions in the group repaired on ECMO, despite the fact that
we used a broader definition of bleeding complications
than did the ELSO registry.Another limitation is the retrospective character of our
study. At Erasmus MC–Sophia, surgery-related bleeding
complications were scored positive if extra-fluid expansion,
transfusion, or relaparotomy caused by postoperative
bleeding was specifically reported in our prospective
computerized PDMS. Although before 2003, information
was retrieved from patient charts, our data were very reliable
from that time point onward because patients were operated
on in the ICU, and therefore, all data including extra fluids
are integrated prospectively in PDMS.
The data from the ELSO registry was lacking demo-
graphic data and potentially very different among centers.
Moreover, the ECMO and anticoagulant protocol used in
ELSO patients was not reported. Differences in anticoag-
ulant protocols could, therefore, result in substantial bias in
this analysis because this was found to be a major
determinant of hemorrhagic complications in our series at
Erasmus MC–Sophia. Surgery-related site bleeding com-
plications reported in the ELSO registry were not well
defined, and data in this registry originate from different
hospitals; hence, correcting for these data is not possible.
Because we used a broader definition of surgery-related site
bleeding complications, our bleeding complications are
probably overestimated as compared with the norm of the
ELSO registry. Our bleeding complications in the on-
ECMO repair group were lower than reported in the ELSO
registry: 12.5% vs 27.6%. We chose not to compare our
numbers statistically to the numbers of the ELSO registry
because of a lack of a clear definition of surgery-related
bleeding complications in the latter group.
Days in the ICU and duration of mechanical ventilation
were reviewed as secondary outcome measures in our series.
We observed a trend toward a shorter ICU stay and a shorter
period of mechanical ventilation in the patients repaired
while on ECMO. This trend was not statistically significant
and is probably more related to modern ICU management
than to the actual repair on ECMO. Because of the small
sample size, matching of patients was not possible. These
parameters were not measured in the population from the
ELSO registry.
Although this is a retrospective study that has its limitations
as stated previously, in our single center with 13-year
experience period, no major surgery-related bleeding compli-
cations were observed in our institution while performing
repair of CDH on ECMO. In addition, we noted a trend toward
a shorter ICU stay and a shorter period of requiringmechanical
ventilation. In the past 5 years, all patients with CDH requiring
ECMOwere repaired while on ECMO in our institute, without
major bleeding complications.
Congenital diaphragmatic hernia repair on ECMO is
feasible, and using a specific anticoagulation protocol with
TEA resulted in a low complication rate. A larger
prospective study should be performed to evaluate whether
there are indeed differences in surgery-related bleeding
complications and which coagulant protocol should be used
to perform CDH repair on ECMO as safely as possible.
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